ZYNE - Zynerba Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6367
Avg. Estimate-0.5-0.47-1.53-1.87
Low Estimate-0.56-0.52-1.58-2.4
High Estimate-0.44-0.4-1.47-1.5
Year Ago EPS-0.44-0.47-2.61-1.53
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6367
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago Sales86kN/A86kN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.65-0.49-0.5-0.52
EPS Actual-0.44-0.47-0.5-0.08
Difference0.210.0200.44
Surprise %32.30%4.10%0.00%84.60%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.5-0.47-1.53-1.87
7 Days Ago-0.5-0.47-1.53-1.87
30 Days Ago-0.51-0.47-1.54-1.88
60 Days Ago-0.51-0.47-1.54-1.88
90 Days Ago-0.53-0.5-2.02-2.03
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/A11
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesZYNEIndustrySectorS&P 500
Current Qtr.-13.60%N/AN/A0.01
Next Qtr.N/AN/AN/A0.06
Current Year41.40%N/AN/A-0.02
Next Year-22.20%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A